To evaluate the impact of chronic proton pump inhibitor (PPI) use on trabecular bone microarchitecture and bone density, with a focus on gender differences and overall effects.
Key Findings:
Chronic PPI use is associated with lower TBS and lumbar spine T-score in men, indicating worse bone health.
No significant association between chronic PPI use and TBS or BMD was found in women, highlighting a potential gender disparity.
The negative impact of PPI use on trabecular bone quality in men remained significant even after adjusting for BMD.
Interpretation:
Chronic PPI use negatively affects trabecular bone quality in men, suggesting a need for monitoring bone health in male patients on long-term PPI therapy, which may inform clinical decision-making.
Limitations:
The study is observational and cannot establish causation.
Data is limited to the NHANES population, which may not represent all demographics.
The observational nature limits the ability to draw causal inferences.
Conclusion:
Chronic PPI use is linked to degraded trabecular bone quality in men, highlighting the importance of considering gender differences in assessing the risks associated with long-term PPI therapy.
